Bullous Pemphigoid associated with Dipeptidyl Peptidase-4 Inhibitors: A Report of Five Cases.
-
- Yoshiji, Satoshi
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
-
- Murakami, Takaaki
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
-
- Harashima, Shinichi
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
-
- Ko, Rie
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
-
- Kashima, Riko
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
-
- Yabe, Daisuke
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
-
- Ogura, Masahito
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
-
- Doi, Kentaro
- Department of Endocrinology and Metabolism, Rakuwakai Otowa Hospital
-
- Inagaki, Nobuya
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine
Search this article
Abstract
Bullous pemphigoid (BP) is an autoimmune blistering skin disorder. Recently, BP induced by dipeptidyl peptidase-4 (DPP-4) inhibitors has been a concern. Although DPP-4 inhibitors are commonly used in the Asian population because of their safety and efficacy, BP associated with DPP-4 inhibitors is sometimes seen in clinical settings. Here, we report five Japanese cases of BP associated with the agents. In the present cases, BP occurred in older adults using four different DPP-4 inhibitors, which showed various clinical manifestations in terms of latency period for BP, sex, glycemic control and diabetes duration. Withdrawal of DPP-4 inhibitors was effective in improving BP, and achieved remission even in cases requiring oral steroid administration and intravenous immunoglobulin therapy. Clinicians should note the importance of early diagnosis of this clinical condition and initiate prompt withdrawal of DPP-4 inhibitors.
Journal
-
- Journal of diabetes investigation
-
Journal of diabetes investigation 9 (2), 445-447, 2018-03-04
Wiley-Blackwell
- Tweet
Details 詳細情報について
-
- CRID
- 1050282810831592576
-
- NII Article ID
- 120006454668
-
- ISSN
- 20401116
-
- HANDLE
- 2433/230429
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- IRDB
- CiNii Articles